FEMTOGENIX
Femtogenix was founded in 2015 to discover and develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates. their payloads are designed through a development platform combining proprietary computational chemistry techniques, and founder know-how gained from a combined 50+ years of experience in DNA-targeted drug discovery and development. Their drug discovery platform allows us to design molecules capable of binding reversibly and/or irreversibly to DNA, in a sequence-interactive manner, leading to exquisite cytotoxicity toward tumour cells. When attached to antibodies or other targeting moieties, these potent cytototoxic agents can be delivered directly to tumours with minimal general systemic toxicities for patients.
FEMTOGENIX
Industry:
Biotechnology Life Science
Founded:
2015-01-01
Address:
Welwyn Garden City, Hertford, United Kingdom
Country:
United Kingdom
Website Url:
http://www.femtogenix.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 203 858 0153
Technology used in webpage:
SPF Euro CPanel SSL Linode
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Official Site Inspections
http://www.femtogenix.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Femtogenix"
Femtogenix - Crunchbase Company Profile & Funding
Femtogenix was founded in 2015 to discover and develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates. their payloads are designed through a …See details»
Femtogenix - VentureRadar
Femtogenix was founded in 2015 to discover and develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates. Our payloads are designed through a …See details»
King's College London and RCT Establish New Anticancer Drug …
Oct 21, 2015 London, United Kingdom – WEBWIRE – Monday, October 19, 2015 A new company, Femtogenix Ltd, has been formed by King's College London and Research …See details»
Femtogenix Company Profile - Office Locations, Competitors
Femtogenix is a biotechnology company developing DNA-interactive payload molecules for use in the antibody-drug conjugate. It provides a development platform designing molecules capable …See details»
Femtogenix - selectscience.net
Femtogenix was founded in 2015 to discover and develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates. Our payloads are designed through a …See details»
Femtogenix Ltd - Drug pipelines, Patents, Clinical trials - Synapse
Explore Femtogenix Ltd with its drug pipeline, therapeutic area, technology platform, 1 news, and 6 literature, Disease Domain:Endocrinology and Metabolic Disease, Neoplasms, Technology …See details»
Femtogenix Ltd.:Company Profile & Technical …
Femtogenix Ltd. is a company that provides Biology, Payload, Drug discovery and more. Femtogenix Ltd. is headquartered in United Kingdom HERTFORD COUNTY. Femtogenix Ltd. …See details»
EIN 88-1393415 - Femtogenix Inc, Cambridge, Massachusetts
Femtogenix Inc is a small employer located at Cambridge, Massachusetts. The employer identification number (EIN) for Femtogenix Inc is 881393415. EIN for organizations is …See details»
www.femtogenix.com
Www.femtogenix.comSee details»
George Procopiou – Pheon Therapeutics
He has over 10 years’ experience in academia and industry, including at GlaxoSmithKline (GSK) and Peakdale Molecular. Prior to Pheon, he led Chemistry at Femtogenix, in particular …See details»
Use of pyrrolobenzodiazepines and related covalent-binding DNA ...
Affiliations 1 Femtogenix Ltd., Biopark, Broadwater Road, Welwyn Garden City AL7 3AX, United Kingdom.; 2 Femtogenix Ltd., Biopark, Broadwater Road, Welwyn Garden City AL7 3AX, …See details»
Company Information - RocketReach
Femtogenix was founded in 2015 to discover and develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates. Our payloads are designed through a …See details»
Pheon Therapeutics Ltd.. (5/21/24). "Press Release: Pheon …
Top News. New Roche Genentech Innovation Center Boston in Allston, MA; Xund Solutions Raises €6m Pre-Series A Round; Trimtech Therapeutics Raises £25m Seed Round for TPDSee details»
Federal government announces support for cutting-edge, AI- and …
17 hours ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for …See details»
Rapid conjugation of antibodies to toxins to select candidates for …
Jun 1, 2020 S.N.K. and J.F.S. are founders and shareholders of Epsilogen Ltd. DET is co-founder of Femtogenix Ltd. All other authors declare no conflicts of interest. Additional …See details»
Working at Femtogenix | Glassdoor
Femtogenix. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your Free …See details»
King’s College London and RCT establish new anticancer drug …
Called Femtogenix, the company will base its business on the research of David Thurston, Professor of Drug Discovery, and his colleagues Miraz Rahman and Paul Jackson at King’s …See details»
Femtogenix Presents Data at AACR Annual Meeting 2018 Showing …
Apr 12, 2018 Femtogenix, Ltd announced it will present data highlighting the high potency of its new generation of DNA binders for ADCs at the American Association for Cancer Research …See details»
Promising Efficacy and Toxicity Data For New Antibody Drug …
Oct 14, 2019 Femtogenix has announced data verifying the favorable toxicity profile and potent efficacy of its Pyridinobenzodiazepine (PDD) antibody-drug conjugate payload platform in …See details»
Pedigree and Risk Assessment Solutions - FamGenix
FamGenix pedigree, family health history and genetic risk assessment software solutions for clinical genetics. Efficient pedigree drawing, cancer risk assessment, patient family history …See details»